1. Home
  2. NURO vs POAI Comparison

NURO vs POAI Comparison

Compare NURO & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NURO
  • POAI
  • Stock Information
  • Founded
  • NURO 1996
  • POAI 2002
  • Country
  • NURO United States
  • POAI United States
  • Employees
  • NURO N/A
  • POAI N/A
  • Industry
  • NURO Medical/Dental Instruments
  • POAI Industrial Specialties
  • Sector
  • NURO Health Care
  • POAI Health Care
  • Exchange
  • NURO Nasdaq
  • POAI Nasdaq
  • Market Cap
  • NURO 8.2M
  • POAI 8.5M
  • IPO Year
  • NURO N/A
  • POAI N/A
  • Fundamental
  • Price
  • NURO $4.38
  • POAI $1.46
  • Analyst Decision
  • NURO
  • POAI Hold
  • Analyst Count
  • NURO 0
  • POAI 1
  • Target Price
  • NURO N/A
  • POAI N/A
  • AVG Volume (30 Days)
  • NURO 21.4K
  • POAI 2.9M
  • Earning Date
  • NURO 02-20-2025
  • POAI 03-27-2025
  • Dividend Yield
  • NURO N/A
  • POAI N/A
  • EPS Growth
  • NURO N/A
  • POAI N/A
  • EPS
  • NURO N/A
  • POAI N/A
  • Revenue
  • NURO $3,767,764.00
  • POAI $1,484,223.00
  • Revenue This Year
  • NURO N/A
  • POAI N/A
  • Revenue Next Year
  • NURO N/A
  • POAI $569.48
  • P/E Ratio
  • NURO N/A
  • POAI N/A
  • Revenue Growth
  • NURO N/A
  • POAI N/A
  • 52 Week Low
  • NURO $2.66
  • POAI $0.55
  • 52 Week High
  • NURO $4.73
  • POAI $3.76
  • Technical
  • Relative Strength Index (RSI)
  • NURO 67.97
  • POAI 59.80
  • Support Level
  • NURO $4.16
  • POAI $1.36
  • Resistance Level
  • NURO $4.40
  • POAI $1.58
  • Average True Range (ATR)
  • NURO 0.09
  • POAI 0.21
  • MACD
  • NURO 0.03
  • POAI -0.01
  • Stochastic Oscillator
  • NURO 95.24
  • POAI 30.58

About NURO NeuroMetrix Inc.

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

Share on Social Networks: